SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-052768
Filing Date
2018-10-05
Accepted
2018-10-05 16:34:07
Documents
1
Period of Report
2018-10-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv504349_4.html 4  
1 OWNERSHIP DOCUMENT tv504349_4.xml 4 4334
  Complete submission text file 0001144204-18-052768.txt   5726
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CIVITAS THERAPEUTICS, INC. 190 EVERETT AVENUE CHELSEA MA 02150
Business Address
Shah Rajeev M. (Reporting) CIK: 0001619841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 181110879